Baxter International reported first-quarter 2026 results with sales of US$2,701 million, a net loss of US$15 million, and a diluted loss per share of US$0.03, while reaffirming full-year guidance for ...
Healthcare company Baxter International (NYSE:BAX) reported in Q1 CY2026, with sales up 2.9% year on year to $2.70 billion.
Healthcare company Baxter International (NYSE:BAX) will be announcing earnings results this Thursday before market hours.
Baxter’s latest quarterly performance highlights steady healthcare demand, evolving strategy, and its positioning within the ...
Baxter’s third quarter results were met with a negative market reaction, as the company delivered top-line growth but missed Wall Street’s revenue expectations. Management attributed performance ...
What we love most about Baxter’s is just how reliable it is. The venue fosters a community-driven environment where anything ...